Benralizumab Normalizes Sputum Eosinophilia in Severe Asthma Uncontrolled by Anti–IL-5 Antibodies: A Single-Blind, Placebo-controlled Clinical Trial
Manali Mukherjee, Chynna Huang, Carmen Venegas-Garrido, Kayla Zhang, Anurag Bhalla, Xiaotian Ju, Paul M. O’Byrne, Sarah Svenningsen, Roma Sehmi, Parameswaran Nair
Abstract
"Benralizumab Normalizes Sputum Eosinophilia in Severe Asthma Uncontrolled by Anti–IL-5 Antibodies: A Single-Blind, Placebo-controlled Clinical Trial." American Journal of Respiratory and Critical Care Medicine, 208(12), pp. 1330–1335
Topics & Concepts
BenralizumabMedicineEosinophiliaSputumPlaceboAsthmaImmunologyInterleukin 5Clinical trialInternal medicineMepolizumabInterleukinEosinophilCytokineAlternative medicinePathologyTuberculosisAsthma and respiratory diseasesRespiratory and Cough-Related ResearchEosinophilic Esophagitis